Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

WDNAvsGNOMETF Comparison

ETF 1
WDNA

WisdomTree BioRevolution Fund

This fund is part of
BioTech & Genomics
-0.45%
VS
ETF 2
GNOM

Global X Genomics & Biotechnology ETF

This fund is part of
BioTech & Genomics
-0.45%

WisdomTree BioRevolution Fund (WDNA) and Global X Genomics & Biotechnology ETF (GNOM) belong to the same industry segment: BioTech & Genomics. WDNA's top 3 sector exposures are Healthcare, Non-Energy Materials and Consumer Non-Cyclicals. In contrast, GNOM's top sector exposures are Healthcare, Industrials  WDNA is less expensive with a Total Expense Ratio (TER) of 0.45%, versus 0.5% for GNOM. WDNA is up 14.72% year-to-date (YTD) with -$357K in YTD flows. GNOM performs better with 19.53% YTD performance, and +$18M in YTD flows. Run a side-by-side ETF comparison of WDNA and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

WDNA vs GNOM performance and flow charts

Performance

-6.0-4.0-2.00.02.04.0%Jun 30Jul 8Jul 15Jul 22Jul 29

Cumulative Flows

0 M2 M4 M6 M8 M10 MJun 30Jul 8Jul 15Jul 22Jul 29

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/31/2026
1M3MYTD1Y3Y5Y
Perf.
WDNA
GNOM
-6.04%-5.51%
+9.28%+19.85%
+14.72%+19.53%
+46.75%+58.84%
+11.95%+12.64%
-20.31%-39.49%
Flows
WDNA
GNOM
-+$7M
-+$19M
-$357K+$18M
-$357K+$13M
-$524K-$95M
+$1M-$7M
Volatility and drawdown
3M1Y3Y5Y
Volatility
WDNA
GNOM
+24.15%+28.51%
+25.21%+26.75%
+25.07%+29.11%
+25.00%+33.33%
Max drawdown
WDNA
GNOM
-9.35%-8.57%
-11.90%-18.16%
-37.36%-43.10%
-58.58%-72.01%
Max drawdown duration
WDNA
GNOM
24d25d
147d145d
876d674d
1793d1793d
Trading data

Create an account to view trading data

Join for free
WDNA
GNOM
Last sale
7/31/2026 at 1:30 PM
$19.45
$54.17
Previous close
07/30/2026
$19.91
$55.39
Consolidated volume
07/30/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of July 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
WDNA
GNOM
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/31/2026 at 1:30 PM
Live
Closed
WDNA
GNOM
Last price
$19.45
$54.17
1D performance
-2.30%
-2.21%
AuM$2.52 M$79.65 M
E/R0.45%0.5%
Characteristics
WDNA
GNOM
Management strategyPassivePassive
ProviderWisdomTreeGlobal X
BenchmarkWisdomTree BioRevolution IndexSolactive Genomics Index
N° of holdings8050
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 3, 2021April 5, 2019
ESGNoNo
Advertisement
Exposure

Countries

WDNA
USA
83.72%
Other
16.28%
GNOM
USA
84.1%
Other
15.9%

Sectors

WDNA
Healthcare
89.22%
Other
10.78%
GNOM
Healthcare
99.75%
Other
0.25%
Advertisement

Diversification

WDNA

Total weight of top 15 holdings out of 15

39.68%
GNOM

Total weight of top 15 holdings out of 15

61.22%

Top 15 holdings

Data as of June 30, 2026
WDNA
Twist Bioscience Corp.
5.81%
Eli Lilly & Co.
3.98%
Moderna, Inc.
3.67%
Johnson & Johnson
2.98%
United Therapeutics Corp.
2.55%
Natera, Inc.
2.32%
Tempus AI, Inc.
2.25%
Immunome, Inc.
2.15%
Beam Therapeutics, Inc.
2.14%
Stoke Therapeutics, Inc.
2.02%
Corteva, Inc.
1.99%
Structure Therapeutics, Inc.
1.98%
Krystal Biotech, Inc.
1.97%
Darling Ingredients, Inc.
1.96%
Ionis Pharmaceuticals, Inc.
1.91%
GNOM
Guardant Health, Inc.
5.78%
Twist Bioscience Corp.
5.09%
Illumina, Inc.
4.67%
Natera, Inc.
4.41%
Moderna, Inc.
4.22%
Veracyte, Inc.
4.12%
Bio-Techne Corp.
4.08%
Vertex Pharmaceuticals, Inc.
3.85%
Legend Biotech Corp.
3.82%
10X Genomics, Inc.
3.70%
Arrowhead Pharmaceuticals, Inc.
3.67%
BioMarin Pharmaceutical, Inc.
3.59%
Praxis Precision Medicines, Inc.
3.50%
CRISPR Therapeutics AG
3.36%
QIAGEN NV
3.35%
Frequently asked questions about WDNA and GNOM

How have the WDNA and GNOM ETFs performed in 2026?

As of July 31, 2026, WDNA is up 14.72% year-to-date (YTD), while GNOM has returned 19.53%. That puts GNOM better performer ahead so far this year.

Which ETF is attracting more investor money: WDNA or GNOM?

Year-to-date, the WDNA ETF saw -$357K in flows, compared to +$18M for GNOM.

Which ETF is more volatile: WDNA or GNOM?

Over the past year, WDNA had a volatility of 25.21%, while GNOM experienced 26.75%.

Which ETF is bigger: WDNA or GNOM?

As of July 31, 2026, WDNA holds $2.52 M in assets under management (AUM), while GNOM manages $79.65 M.

What sectors do the WDNA and GNOM ETFs invest in?

WDNA leans toward sectors like Healthcare. Meanwhile, GNOM focuses on Healthcare.

What are the top holdings of the WDNA ETF and GNOM ETF?

WDNA top holdings include Twist Bioscience Corp., Eli Lilly & Co. and Moderna, Inc.. GNOM holds in its top three: Guardant Health, Inc., Twist Bioscience Corp. and Illumina, Inc..

Which ETF is more diversified: WDNA or GNOM?

WDNA holds 80 securities with 39.68% of its assets in the top 15. GNOM has 50 securities and a top 15 weight of 61.22%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up